Home

Why Choose Medcrave Mission & Vision Partners & Supporters News & Press Release

Journals eBooks Videos Reprints

Magazines Editors-in-Chief FAQs Contact Us ☰

Dual phosphodiesterase 3 and 4 inhibition in chronic obstructive pulmonary disease: mechanistic rationale and clinical translation of Ensifentrine

: Journal of Lung, Pulmonary & Respiratory Research
: Prakhar Anand,¹ Mark Georgy,¹ Yashi Ballal,² Mahtab Nezafat,³ Raghav Gupta⁴

PDF Full Text

Keywords

chronic obstructive pulmonary disease, ensifentrine, phosphodiesterase 3/4 inhibition, exacerbations, bronchodilation, airway inflammation

© 2014-2026 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at www.medcrave.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera | Terms and Conditions | Privacy Policy

Testimonials